News on haematological malignancies
Simultaneous infection by two viruses could be the key to study rare lymphoma
New research has found that a rare blood cancer can be simulated in the lab…
Browsing: Haematology
New therapy to treat drug-resistant acute lymphoblastic leukaemia
Acute lymphoblastic leukaemia accounts for one in five adult leukaemias. While new immune therapies have…
Inherited BRCA2 mutations linked to increased risk of childhood lymphoma
A report from St. Jude Children’s Research Hospital links inherited mutations in the BRCA2 gene…
EHA 2019: Labour is the most frequent outcome in the European Leukaemia Net registry of patients with chronic myeloid leukaemia and pregnancy
Family planning is an important issue for the CML patients of childbearing potential, because they…
EHA 2019: Genomic evidence of residual disease in patients in remission prior to stem cell transplant; fate or opportunity for early intervention?
Acute myeloid leukaemia (AML) is a rare, highly fatal blood cancer. Allogeneic haematopoietic cell transplantation…
Study reports ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients
Ibrutinib and venetoclax, two FDA-approved drugs for treating chronic lymphocytic leukemia (CLL), have been shown…
Towards a safer treatment for leukaemia
An international team of researchers at VIB-KU Leuven, Belgium, the UK Dementia Institute and the…
Patterns of chronic lymphocytic leukaemia growth identified
In patients with chronic lymphocytic leukaemia (CLL), the rate of disease growth is apt to…
Recovery twice as hard for survivors of childhood acute lymphoblastic leukaemia
Nearly 90 per cent of children with acute lymphoblastic leukaemia (ALL) survive, yet the same…
Researchers pinpoint why lymphoma patients may become resistant to specific therapy
With more targeted therapies being approved each year for cancer, the development of drug resistance…